Stphen M Feinstone

Title: The Innovations of Stphen M Feinstone

Introduction

Stphen M Feinstone is a notable inventor based in Washington, DC. He has made significant contributions to the field of virology, particularly in the development of vaccines. His work has been recognized for its impact on public health.

Latest Patents

Feinstone holds a patent for a cDNA encoding an attenuated cell culture-adapted hepatitis A virus genome. This patent describes the construction of a full-length cDNA copy of the hepatitis A virus genome. The HAV cDNA, when inserted into an RNA transcription vector, resulted in a plasmid designated pHAV/7. Transfection of monkey kidney cells with pHAV/7 DNA successfully yielded hepatitis A virus. Furthermore, transfection with RNA transcripts produced in vitro from pHAV/7 resulted in approximately tenfold more virus than transfection with pHAV/7 DNA. The HAV produced through this method is useful as a vaccine.

Career Highlights

Feinstone's career has been marked by his dedication to advancing vaccine development. His work has been instrumental in understanding and combating hepatitis A. He is affiliated with the United States of America as represented by the Department of Health, where he continues to contribute to public health initiatives.

Collaborations

Throughout his career, Feinstone has collaborated with esteemed colleagues, including Jeffrey I Cohen and Robert H Purcell. These collaborations have furthered research in virology and vaccine development.

Conclusion

Stphen M Feinstone's contributions to the field of virology and vaccine development are noteworthy. His innovative work in creating a vaccine for hepatitis A has had a lasting impact on public health. His dedication to research and collaboration continues to inspire advancements in medical science.